Home / Companies / Nartex Laboratorios Homeopaticos S.A. De C.V.

Nartex Laboratorios Homeopaticos S.A. De C.V. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Latest inspection VAI · Dec 15, 2023
Last warning letter 2020

Inspections 2

1 OAI

Recalls 0 0 Class I

Warning letters 1 Latest Nov 4, 2020

510(k) clearances 0 None on file

Nartex Laboratorios Homeopaticos S.A. De C.V. has 0 FDA recalls, 2 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Nartex Laboratorios Homeopaticos S.A. De C.V., the most recent on Nov 4, 2020.

What these totals cover: FDA records filed under the name "Nartex Laboratorios Homeopaticos S.A. De C.V." and its spelling variant "Nartex Laboratorios Homeopaticos S.A. De C.V".

Latest inspection: Dec 15, 2023 · VAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 8, 2026	File dated Nov 3, 2026	Current
510(k) clearances	0	Nov 8, 2026	File dated Nov 2, 2026	Current
Inspections	2	Nov 14, 2026	Newest record Nov 5, 2026	Current
Compliance actions	1	Nov 2, 2026	Newest record Oct 29, 2026	Current

FDA record by year

Nartex Laboratorios Homeopaticos S.A. De C.V.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Nartex Laboratorios Homeopaticos S.A. De C.V.: FDA inspections per year

Year	Inspections	OAI	Warning letters
2026	0	0	0
2025	0	0	0
2024	0	0	0
2023	1	0	0
2022	0	0	0
2021	0	0	0
2020	1	1	1
2019	0	0	0
2018	0	0	0
2017	0	0	0

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Nartex Laboratorios Homeopaticos S.A. De C.V. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Nartex Laboratorios Homeopaticos S.A. De C.V. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Nartex Laboratorios Homeopaticos S.A. De C.V. FDA Warning Letters

1 warning letter on Nov 4, 2020.

Issued	Subject	Issuing office	Close-out letter
Nov 4, 2020 · Letter on fda.gov		Center for Drug Evaluation and Research \| CDER

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent FDA inspections

2 inspections from Feb 28, 2020 to Dec 15, 2023.

Date	Site	Product	Classification	FEI
Dec 15, 2023	Torreon, Mexico	Drugs	Voluntary Action Indicated (VAI)	3009407408
Feb 28, 2020	Torreon, Mexico	Drugs	Official Action Indicated (OAI)	3009407408

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Nartex Laboratorios Homeopaticos S.A. De C.V.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Nov 4, 2020.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

Facility	Location	Inspections	Latest
FEI 3009407408	Torreon, Mexico	2	Dec 15, 2023

Nartex Laboratorios Homeopaticos S.A. De C.V. and the FDA: common questions

Has Nartex Laboratorios Homeopaticos S.A. De C.V. received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Nartex Laboratorios Homeopaticos S.A. De C.V.. The most recent is dated Nov 4, 2020.

Has Nartex Laboratorios Homeopaticos S.A. De C.V. received an FDA Form 483?

FDA has not published a Form 483 for "Nartex Laboratorios Homeopaticos S.A. De C.V." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Nartex Laboratorios Homeopaticos S.A. De C.V.?

The most recent FDA inspection on file ended Dec 15, 2023 at Torreon, Mexico and was classified VAI. FDA has 2 inspections of Nartex Laboratorios Homeopaticos S.A. De C.V. on file, 1 of them classified OAI (official action indicated).

Need more than this page shows? Ask about Nartex Laboratorios Homeopaticos S.A. De C.V. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.